Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
AstraZeneca
Merck
Baxter
Moodys

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Meso-Erythritol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Meso-Erythritol?

Meso-Erythritol is an investigational drug.

There have been 18 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2018.

The most common disease conditions in clinical trials are Mesothelioma, Lung Neoplasms, and Neoplasms, Glandular and Epithelial. The leading clinical trial sponsors are Hrain Biotechnology Co.,Ltd., Stony Brook University, and Ministry of Health, Israel.

There is one US patent protecting this investigational drug and twenty-three international patents.

Recent Clinical Trials for Meso-Erythritol
TitleSponsorPhase
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaHoffmann-La RochePhase 3
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaEuropean Thoracic Oncology PlatformPhase 3
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian CancerHrain Biotechnology Co.,Ltd.Early Phase 1

See all Meso-Erythritol clinical trials

Clinical Trial Summary for Meso-Erythritol

Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol

See all Meso-Erythritol clinical trials

US Patents for Meso-Erythritol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meso-Erythritol   Start Trial Agent for the treatment of wounds Smith & Nephew Medical Ltd. (GB2)   Start Trial
Meso-Erythritol   Start Trial Silver halide color photographic material containing sparingly water soluble epoxy compound and organic soluble polymer Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Meso-Erythritol   Start Trial Solvent resistant polyetherpolyurethane products The Dow Chemical Company (Midland, MI)   Start Trial
Meso-Erythritol   Start Trial Silver halide color photographic material having improved dye image stability Fuji Photo Film Co. Ltd. (Tokyo, JP)   Start Trial
Meso-Erythritol   Start Trial Silver halide color photographic material which forms a color photographic image with improved preservability Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Meso-Erythritol

Drugname Country Document Number Estimated Expiration Related US Patent
Meso-Erythritol Austria 53302 2002-07-14   Start Trial
Meso-Erythritol Australia 1669383 2002-07-14   Start Trial
Meso-Erythritol Australia 575296 2002-07-14   Start Trial
Meso-Erythritol Canada 1222454 2002-07-14   Start Trial
Meso-Erythritol Germany 3226753 2002-07-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
McKinsey
Mallinckrodt
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.